| Michael Rodriguez, DO | |
|
20325 N 51st Ave Ste 154, Glendale, AZ 85308-4622 | |
| (623) 900-4740 | |
| (855) 398-9290 |
| Full Name | Michael Rodriguez |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 8 Years |
| Location | 20325 N 51st Ave Ste 154, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528356284 | NPI | - | NPPES |
| 117932 | Medicaid | AZ | |
| 006885 | Other | AZ | AZ DO LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 006885 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adobe Ent And Allergy Llc | 0941637581 | 4 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.
At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker's MALDI Biotyper molecular identification solution.
Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis.
A widely cited statistic suggests that health care services account for only a small percentage of the variation in American life expectancy. However, the methodology supporting the finding has been challenged.
› Verified 5 days ago
| Entity Name | Enticare Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710014410 PECOS PAC ID: 2264532779 Enrollment ID: O20070713000056 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.
At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker's MALDI Biotyper molecular identification solution.
Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis.
A widely cited statistic suggests that health care services account for only a small percentage of the variation in American life expectancy. However, the methodology supporting the finding has been challenged.
› Verified 5 days ago
| Entity Name | Adobe Ent & Allergy Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467914259 PECOS PAC ID: 0941637581 Enrollment ID: O20200220002772 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.
At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker's MALDI Biotyper molecular identification solution.
Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis.
A widely cited statistic suggests that health care services account for only a small percentage of the variation in American life expectancy. However, the methodology supporting the finding has been challenged.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Rodriguez, DO 20325 N 51st Ave Ste 154, Glendale, AZ 85308-4622 Ph: (623) 900-4740 | Michael Rodriguez, DO 20325 N 51st Ave Ste 154, Glendale, AZ 85308-4622 Ph: (623) 900-4740 |
News Archive
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that pretargeted therapy with TF2, a bispecific antibody against carcinoembryonic antigen (CEA) and a small peptide, delayed tumor growth and prolonged survival in an animal model of human colonic cancer.
At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their accreditation according to DIN EN ISO 15189 to include the use of Bruker's MALDI Biotyper molecular identification solution.
Rensselaer Polytechnic Institute Biologist Lee Ligon has found a previously unknown connection between breast cancer tumor cells and the surrounding healthy tissue. The results provide new information on the earliest stages of breast cancer metastasis.
A widely cited statistic suggests that health care services account for only a small percentage of the variation in American life expectancy. However, the methodology supporting the finding has been challenged.
› Verified 5 days ago
Dr. David L Simms, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5750 W. Thunderbird Rd, Suite A-100, Glendale, AZ 85306 Phone: 602-938-3205 Fax: 602-938-5799 | |
Dr. Gordon E Chait, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5750 W Thunderbird Rd, Ste. A-100, Glendale, AZ 85306 Phone: 602-938-3205 Fax: 602-938-5799 | |
Sudhir P Agarwal, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5757 W Thunderbird Road, Suite W301, Glendale, AZ 85306 Phone: 602-938-3777 Fax: 602-547-0379 | |
Elliot Martin Libling, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18700 N 64th Dr, Ste 312, Glendale, AZ 85308 Phone: 623-566-4718 Fax: 623-566-4820 | |
Ravi P Agarwal, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5757 W Thunderbird Rd, Suite W301, Glendale, AZ 85306 Phone: 602-938-3777 Fax: 602-547-0379 | |
Stephanie Diana Warrington, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5750 W Thunderbird Rd Ste A100, Glendale, AZ 85306 Phone: 602-938-3205 Fax: 602-938-5799 |